120 related articles for article (PubMed ID: 18632816)
1. Whole-body biodistribution and radiation dosimetry of the new cardiac tracer 99mTc-N-DBODC.
Cittanti C; Uccelli L; Pasquali M; Boschi A; Flammia C; Bagatin E; Casali M; Stabin MG; Feggi L; Giganti M; Duatti A
J Nucl Med; 2008 Aug; 49(8):1299-304. PubMed ID: 18632816
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and biodistribution of 99mTc N-MPO in healthy human volunteers.
Gao S; Zhao G; Wen Q; Bai L; Chen B; Ji T; Ji B; Ma Q
Clin Nucl Med; 2014 Jan; 39(1):e14-9. PubMed ID: 23917788
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent.
Higley B; Smith FW; Smith T; Gemmell HG; Das Gupta P; Gvozdanovic DV; Graham D; Hinge D; Davidson J; Lahiri A
J Nucl Med; 1993 Jan; 34(1):30-8. PubMed ID: 8418268
[TBL] [Abstract][Full Text] [Related]
5. [Myocardial perfusion imaging with [(99m)Tc (N) (PNP5) (DBODC)](+) in canine model of acute myocardial ischemia].
Zhang WC; Fang W; Wang XB; Li B; Tang ZG; Guo F; Guo L; Geng QH; He ZX
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Oct; 35(10):949-55. PubMed ID: 18206048
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans.
Kemerink GJ; Boersma HH; Thimister PW; Hofstra L; Liem IH; Pakbiers MT; Janssen D; Reutelingsperger CP; Heidendal GA
Eur J Nucl Med; 2001 Sep; 28(9):1373-8. PubMed ID: 11585297
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution, dosimetry, and safety of myocardial perfusion imaging agent 99mTcN-NOET in healthy volunteers.
Vanzetto G; Fagret D; Pasqualini R; Mathieu JP; Chossat F; Machecourt J
J Nucl Med; 2000 Jan; 41(1):141-8. PubMed ID: 10647617
[TBL] [Abstract][Full Text] [Related]
8. Experimental study of [99mTc(PNP5) (DBODC)]+ as a new myocardial perfusion imaging agent.
Zhang WC; Fang W; Li B; Wang XB; He ZX
Cardiology; 2009; 112(2):89-97. PubMed ID: 18583906
[TBL] [Abstract][Full Text] [Related]
9. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
[TBL] [Abstract][Full Text] [Related]
10. A class of asymmetrical nitrido 99mTc heterocomplexes as heart imaging agents with improved biological properties.
Boschi A; Bolzati C; Uccelli L; Duatti A; Benini E; Refosco F; Tisato F; Piffanelli A
Nucl Med Commun; 2002 Jul; 23(7):689-93. PubMed ID: 12089492
[TBL] [Abstract][Full Text] [Related]
11. Biokinetics and dosimetry analysis in healthy volunteers for a two-injection (rest-stress) protocol of the myocardial perfusion imaging agent technetium 99m-labeled Q3.
Rohe RC; Thomas SR; Stabin MG; Deutsch EA; Gerson MC; Cummings DD; Maxon HR
J Nucl Cardiol; 1995; 2(5):395-404. PubMed ID: 9420819
[TBL] [Abstract][Full Text] [Related]
12. [Phase I clinical trial of a new myocardial imaging agent, 99mTc-PPN1011].
Kubo A; Nakamura K; Hashimoto J; Sammiya T; Iwanaga S; Hashimoto S; Sasaki Y
Kaku Igaku; 1992 Oct; 29(10):1165-76. PubMed ID: 1464955
[TBL] [Abstract][Full Text] [Related]
13. Human biodistribution, dosimetry and clinical use of technetium(III)-99m-Q12.
Rossetti C; Vanoli G; Paganelli G; Kwiatkowski M; Zito F; Colombo F; Bonino C; Carpinelli A; Casati R; Deutsch K
J Nucl Med; 1994 Oct; 35(10):1571-80. PubMed ID: 7931652
[TBL] [Abstract][Full Text] [Related]
14. Effect of time on liver clearance of technetium-99m-tetrofosmin in patients with acute chest pain: when should imaging begin?
Mann A; Ahlberg AW; White MP; Cross DM; Piriz J; Morris RS; Heller GV
J Nucl Med Technol; 1998 Sep; 26(3):186-90. PubMed ID: 9755438
[TBL] [Abstract][Full Text] [Related]
15. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K
J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
[TBL] [Abstract][Full Text] [Related]
16. Subcellular distribution and metabolism studies of the potential myocardial imaging agent [99mTc(N)(DBODC)(PNP5)]+.
Bolzati C; Cavazza-Ceccato M; Agostini S; Tokunaga S; Casara D; Bandoli G
J Nucl Med; 2008 Aug; 49(8):1336-44. PubMed ID: 18632814
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 99mTc-tetrofosmin uptakes on planar images with those in excised rats organs.
Onoguchi M; Takayama T; Tonami N; Kyogoku S; Naoi Y; Irimoto M; Maehara T
Ann Nucl Med; 2001 Feb; 15(1):33-40. PubMed ID: 11355779
[TBL] [Abstract][Full Text] [Related]
18. Influence of the different biokinetics of sestamibi and tetrofosmin on the interpretation of myocardial perfusion imaging in daily practice.
Hambÿe AS; Delsarte P; Vervaet AM
Nucl Med Commun; 2007 May; 28(5):383-90. PubMed ID: 17414888
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of novel cationic (99m)Tc-nitrido complexes as radiopharmaceuticals for heart imaging: improving liver clearance with crown ether groups.
Liu S; He Z; Hsieh WY; Kim YS
Nucl Med Biol; 2006 Apr; 33(3):419-32. PubMed ID: 16631092
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
Flamen P; Bossuyt A; Franken PR
J Nucl Med; 1995 Nov; 36(11):2009-15. PubMed ID: 7472590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
